Liminatus Pharma, Inc. (LIMN) › Operating Cash FlowLiminatus Pharma, Inc. (LIMN) — Operating Cash FlowAnnual figures by fiscal year, from SEC filings.2024: -$1.45M2025: -$9.96M-$9.96M2024Operating Cash Flow (USD)2025Fiscal YearOperating Cash FlowChange YoY2025-$9.96M-586.6%2024-$1.45M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsCapital ExpendituresShares OutstandingDividends Per Share